Skip to Main Content


Skip Nav Destination

Phase I Trial of a PSA based vaccine and ipilimumab in patients (pts) with metastatic castrate resistant prostate cancer (CRPC)

Mol Cancer Ther (2007) 6 (11_Supplement): A142.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal